Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gibb

Showing results (321-330 of 368) with videos related to

Pageof 37
Sort By:
Plos One|May 1, 2012
Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and ZimbabweAntonieta Medina Lara, Jesse Kigozi, Jovita Amurwon, et al.
The Lancet. HIV|February 21, 2022
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trialHylke Waalewijn, Man K Chan, Pauline D J Bollen, et al.
Clinical Pharmacokinetics|August 21, 2023
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and AdolescentsHardik Chandasana, Mita Thapar, Siobhan Hayes, et al.
BMC Medical Research Methodology|February 21, 2022
Borrowing information across patient subgroups in clinical trials, with application to a paediatric trialRebecca M Turner, Anna Turkova, Cecilia L Moore, et al.
Antiviral Therapy|February 17, 2007
A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trialHannah Green, Diana M Gibb, Alexandra Compagnucci, et al.
Journal of Virus Eradication|February 20, 2016
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected childrenP Palma, C Foster, P Rojo, et al.
NEJM Evidence|December 18, 2024
A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant TuberculosisTrinh Duong, Joanna Brigden, H Simon Schaaf, et al.
AIDS (London, England)|December 11, 2020
Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen statusSarah L Pett, Moira Spyer, Lewis J Haddow, et al.
Trials|December 31, 2015
Transfusion and Treatment of severe anaemia in African children (TRACT): a study protocol for a randomised controlled trialAyub Mpoya, Sarah Kiguli, Peter Olupot-Olupot, et al.
The New England Journal of Medicine|July 21, 2017
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in AfricaJames Hakim, Victor Musiime, Alex J Szubert, et al.
Pageof 37

Showing results (321-330 of 368) with videos related to

Sort By:
Pageof 37
Plos One|May 1, 2012
Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and ZimbabweAntonieta Medina Lara, Jesse Kigozi, Jovita Amurwon, et al.
The Lancet. HIV|February 21, 2022
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trialHylke Waalewijn, Man K Chan, Pauline D J Bollen, et al.
Clinical Pharmacokinetics|August 21, 2023
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and AdolescentsHardik Chandasana, Mita Thapar, Siobhan Hayes, et al.
BMC Medical Research Methodology|February 21, 2022
Borrowing information across patient subgroups in clinical trials, with application to a paediatric trialRebecca M Turner, Anna Turkova, Cecilia L Moore, et al.
Antiviral Therapy|February 17, 2007
A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trialHannah Green, Diana M Gibb, Alexandra Compagnucci, et al.
Journal of Virus Eradication|February 20, 2016
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected childrenP Palma, C Foster, P Rojo, et al.
NEJM Evidence|December 18, 2024
A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant TuberculosisTrinh Duong, Joanna Brigden, H Simon Schaaf, et al.
AIDS (London, England)|December 11, 2020
Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen statusSarah L Pett, Moira Spyer, Lewis J Haddow, et al.
Trials|December 31, 2015
Transfusion and Treatment of severe anaemia in African children (TRACT): a study protocol for a randomised controlled trialAyub Mpoya, Sarah Kiguli, Peter Olupot-Olupot, et al.
The New England Journal of Medicine|July 21, 2017
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in AfricaJames Hakim, Victor Musiime, Alex J Szubert, et al.
Pageof 37